Skip to content

Research & Literature

Last updated:

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature

Visualize citation networks across 39 referenced papers

Top Authors

Top Institutions

References

  1. 1

    Selective dorsal rhizotomy for spastic diplegia secondary to stroke in an adult patient.

    Eppinger MA, Berman CM, Mazzola CA

    Surgical neurology international 2015; (6()):111 doi:10.4103/2152-7806.159382.

    PMID: 26167363
  2. 2

    Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.

    Roy U, Das U, Pandit A, Debnath A

    BMJ case reports 2016; (2016()):10.1136/bcr-2016-215110.

    PMID: 27095813
  3. 3

    Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

    Rizzo WB

    Expert opinion on orphan drugs 2016; (4(4)):395-406 doi:10.1517/21678707.2016.1154453.

    PMID: 27547594
  4. 4

    Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome.

    Hidalgo ET, Orillac C, Hersh A, et al.

    Journal of child neurology 2017; (32(1)):100-103 doi:10.1177/0883073816671440.

    PMID: 28257279
  5. 5

    Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome.

    Cho KH, Shim SH, Kim M

    Clinical genetics 2018; (93(4)):721-730 doi:10.1111/cge.13058.

    PMID: 28543186
  6. 6

    Understanding fetal factors that contribute to preterm birth: Sjögren-Larsson syndrome as a model.

    Staps P, Hogeveen M, Fuijkschot J, et al.

    Journal of perinatal medicine 2018; (46(5)):523-529 doi:10.1515/jpm-2017-0187.

    PMID: 28915122
  7. 7

    Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran.

    Kariminejad A, Barzgar M, Bozorgmehr B, et al.

    European journal of medical genetics 2018; (61(3)):139-144 doi:10.1016/j.ejmg.2017.11.006.

    PMID: 29183715
  8. 8

    Sjögren-Larsson syndrome: definitive diagnosis on magnetic resonance spectroscopy.

    Poojary S, Shah M

    Cutis 2017; (100(6)):452-455.

    PMID: 29360893
  9. 9

    Clinical and molecular characterization and response to acitretin in three families with Sjögren-Larsson syndrome.

    Vural S, Vural A, Akçimen F, et al.

    International journal of dermatology 2018; (57(7)):843-848 doi:10.1111/ijd.14013.

    PMID: 29704247
  10. 10

    Neurodegeneration in an adolescent with Sjogren-Larsson syndrome: a decade-long follow-up case report.

    Cho KH, Shim SH, Jung Y, et al.

    BMC medical genetics 2018; (19(1)):152 doi:10.1186/s12881-018-0663-0.

    PMID: 30157790
  11. 11

    Genotype and phenotype variability in Sjögren-Larsson syndrome.

    Weustenfeld M, Eidelpes R, Schmuth M, et al.

    Human mutation 2019; (40(2)):177-186 doi:10.1002/humu.23679.

    PMID: 30372562
  12. 12

    [Sjögren-Larsson syndrome: Pediatric case report].

    García-Ortiz L, Gómez-López R, Rivera-Pedroza CI, et al.

    Archivos argentinos de pediatria 2018; (116(6)):e773-e777 doi:10.5546/aap.2018.e773.

    PMID: 30457735
  13. 13

    Daily Functioning and Quality of Life in Patients with Sjögren-Larsson Syndrome.

    Staps P, de Groot IJM, van Gerven MHJC, Willemsen MAAP

    Neuropediatrics 2019; (50(2)):89-95 doi:10.1055/s-0038-1676854.

    PMID: 30609437
  14. 14

    Retinal Morphology in Sjögren-Larsson Syndrome on OCT: From Metabolic Crystalline Maculopathy to Early-Onset Macular Degeneration.

    Staps P, Cruysberg JRM, Roeleveld N, et al.

    Ophthalmology. Retina 2019; (3(6)):500-509 doi:10.1016/j.oret.2019.01.023.

    PMID: 31174672
  15. 15

    Phenotypic and mutational spectrum of thirty-five patients with Sjögren-Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects.

    Abdel-Hamid MS, Issa MY, Elbendary HM, et al.

    Journal of human genetics 2019; (64(9)):859-865 doi:10.1038/s10038-019-0637-x.

    PMID: 31273323
  16. 16

    Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.

    Amr K, El-Bassyouni HT, Ismail S, et al.

    Archives of dermatological research 2019; (311(9)):721-730 doi:10.1007/s00403-019-01953-6.

    PMID: 31388754
  17. 17

    Sjögren-Larsson syndrome: a complex metabolic disease with a distinctive ocular phenotype.

    Fouzdar-Jain S, Suh DW, Rizzo WB

    Ophthalmic genetics 2019; (40(4)):298-308 doi:10.1080/13816810.2019.1660379.

    PMID: 31512987
  18. 18

    Compound heterozygous mutations in the ALDH3A2 gene cause Sjögren-Larsson syndrome: a case report.

    Liu YD, Lin HJ, Li CY, et al.

    The International journal of neuroscience 2020; (130(11)):1156-1160 doi:10.1080/00207454.2020.1716750.

    PMID: 31944864
  19. 19

    Sjogren-Larsson Syndrome: Mechanisms and Management.

    Bindu PS

    The application of clinical genetics 2020; (13()):13-24 doi:10.2147/TACG.S193969.

    PMID: 32021380
  20. 20

    Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene.

    Udhaya Kumar S, Thirumal Kumar D, Mandal PD, et al.

    Advances in protein chemistry and structural biology 2020; (120()):349-377 doi:10.1016/bs.apcsb.2019.11.004.

    PMID: 32085885
  21. 21

    Sjögren-Larsson syndrome: The mild end of the phenotypic spectrum.

    Staps P, van Gaalen J, van Domburg P, et al.

    JIMD reports 2020; (53(1)):61-70 doi:10.1002/jmd2.12099.

    PMID: 32395410
  22. 22

    Macular crystalline inclusions in Sjögren-Larsson syndrome are dynamic structures that undergo remodeling.

    Al-Holou SN, Siefker E, Fouzdar-Jain S, et al.

    Ophthalmic genetics 2020; (41(4)):381-385 doi:10.1080/13816810.2020.1776340.

    PMID: 32506993
  23. 23

    Disturbed brain ether lipid metabolism and histology in Sjögren-Larsson syndrome.

    Staps P, Rizzo WB, Vaz FM, et al.

    Journal of inherited metabolic disease 2020; (43(6)):1265-1278 doi:10.1002/jimd.12275.

    PMID: 32557630
  24. 24

    Sjogren-Larsson Syndrome: A case series of five members from an extended family with a novel mutation.

    Abidi KT, Kamal NM, Bakkar A AA, et al.

    Molecular genetics & genomic medicine 2020; (8(11)):e1487 doi:10.1002/mgg3.1487.

    PMID: 32930514
  25. 25

    Sjögren-Larsson syndrome: Anesthetic considerations and practical recommendations.

    Franzen MH, LeRiger MM, Pellegrino KP, et al.

    Paediatric anaesthesia 2020; (30(12)):1390-1395 doi:10.1111/pan.14034.

    PMID: 33037729
  26. 26

    Muscle Tone Assessment under General Anesthesia for Sjögren-Larsson Syndrome and Spasticity.

    Georgoulis G, Dinopoulos A, Gkliatis E

    Pediatric neurosurgery 2021; (56(2)):163-165 doi:10.1159/000514329.

    PMID: 33725695
  27. 27

    A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.

    Warrack S, Love T, Rizzo WB

    Journal of child neurology 2021; (36(11)):1011-1016 doi:10.1177/08830738211029390.

    PMID: 34315315
  28. 28

    Impaired Skin Barrier Function Due to Reduced ω-O-Acylceramide Levels in a Mouse Model of Sjögren-Larsson Syndrome.

    Nojiri K, Fudetani S, Arai A, et al.

    Molecular and cellular biology 2021; (41(10)):e0035221 doi:10.1128/MCB.00352-21.

    PMID: 34370553
  29. 29

    Infantile onset ascending hereditary spastic paralysis.

    Eltoum A, O'Rourke D, Sharif F

    BMJ case reports 2022; (15(1)) doi:10.1136/bcr-2020-240941.

    PMID: 35039335
  30. 30

    Sjögren-Larsson syndrome: A biochemical rationale for using aldehyde-reactive therapeutic agents.

    Rizzo WB, S'aulis D, Dorwart E, Bailey Z

    Molecular genetics and metabolism reports 2022; (30()):100839 doi:10.1016/j.ymgmr.2021.100839.

    PMID: 35242571
  31. 31

    Small touches to big walks -the impact of rehabilitation on Sjögren-Larsson syndrome: A case report.

    Yolcu G, Huseynli L, Kenis-Coskun O, Karadag-Saygi E

    Journal of pediatric rehabilitation medicine 2022; (15(3)):533-537 doi:10.3233/PRM-201521.

    PMID: 35871376
  32. 32

    Ceramide profiling of stratum corneum in Sjögren-Larsson syndrome.

    Arai A, Takeichi T, Wakamoto H, et al.

    Journal of dermatological science 2022; (107(3)):114-122 doi:10.1016/j.jdermsci.2022.08.003.

    PMID: 35973883
  33. 33

    Sjögren-Larsson Syndrome: A Rare Presentation With Developmental Delay.

    J SK, Waheed MD, Batool S, et al.

    Cureus 2023; (15(2)):e35159 doi:10.7759/cureus.35159.

    PMID: 36950004
  34. 34

    End-stage crystalline maculopathy with retinal atrophy in Sjögren-Larsson syndrome: a case report and review of the literature.

    Lambert LH, Shaikh N, Marx JL, Ramsey DJ

    Therapeutic advances in rare disease 2022; (3()):26330040221122496 doi:10.1177/26330040221122496.

    PMID: 37180414
  35. 35

    Discovery of novel diagnostic biomarkers for Sjögren-Larsson syndrome by untargeted lipidomics.

    Vaz FM, Staps P, van Klinken JB, et al.

    Biochimica et biophysica acta. Molecular and cell biology of lipids 2024; (1869(2)):159447 doi:10.1016/j.bbalip.2023.159447.

    PMID: 38181883
  36. 36

    Accumulation of ether phospholipids in induced pluripotent stem cells and oligodendrocyte-lineage cells established from patients with Sjögren-Larsson syndrome.

    Yamaguchi Y, Okuno H, Tokuoka S, et al.

    Congenital anomalies 2025; (65(1)):e12587 doi:10.1111/cga.12587.

    PMID: 39617394
  37. 37

    Ciliopathy: Sjögren-Larsson Syndrome.

    Tsang SH, Aycinena ARP, Sharma T

    Advances in experimental medicine and biology 2025; (1467()):195-196 doi:10.1007/978-3-031-72230-1_36.

    PMID: 40736838
  38. 38

    Dupilumab Reduces Pruritus in Twins With Sjögren-Larsson Syndrome.

    Gallagher K, Yousif R, Hummel K, Paller AS

    Pediatric dermatology 2025; doi:10.1111/pde.70073.

    PMID: 41046861
  39. 39

    General Anesthesia for a Child With Sjögren-Larsson Syndrome.

    Asahi Y, Omichi S, Tsukamoto H, et al.

    Anesthesia progress 2026; (73(1)):44-47 doi:10.2344/24-0053.

    PMID: 41791722